HighVista Biotechnology Specialist Fund Ltd. — Form D/A
HighVista Biotechnology Specialist Fund Ltd. of BOSTON, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2024-07-12. $188.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-07-12
- Form: D/A
- Accession: 0001871686-24-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $188.1M
- Minimum investment: $5.0M
- Investors: 3
- Date of first sale: 2021-07-01
- Security types: fund interests
- SEC file number: 021-406351
Issuer
- Name: HighVista Biotechnology Specialist Fund Ltd.
- CIK: 0001871686
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2021
- Address: C/O HIGHVISTA STRATEGIES LLC 200 CLARENDON STREET, 50TH FLOOR, BOSTON, MA, 02116
- Phone: (617) 406-6500
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Ruan van Vuuren | Related Person | Grand Cayman, E9 |
| Philip Cater | Related Person | George Town, Grand Cayman, E9 |
| Ronald Landen | Related Person | Boston, MA |
| Raphael A Schorr | Director | Boston, MA |
| Ruan A Van Vuuren | Director | Grand Cayman, E9 |
| N/A A HighVista Strategies LLC | Executive Officer | Boston, MA |
| Karl A O'Reilly | Director | Grand Cayman, E9 |
| Philip A Cater | Director | George Town, Grand Cayman, E9 |
Other filings by this issuer (5)
More